全球药物市场如一幅丰富的画卷，主要由两种角色主导——品牌药（Brand Name Drug）与仿制药（Generic Drug）。这场故事的起点，无疑要追溯到美国的创新土壤。品牌药是制药巨头的专利瑰宝，当一款新药经FDA严格审批，原研公司凭借专利权，倾力打造并投入市场。它们以其独特的疗效和安全性能，赢得了患者的信...
目前世界上在市场上的药基本上可以分为两种类型类,品牌药(Brand Name Drug)和仿制药(Generic Drug),而这两个概念则来源于美国。品牌药是指某一制药公司发现的药物获得FDA上市批准之后,原产制药公司持续生产的持有专利权的药物;仿制药则是指当品牌药的专利保护到期之后,其他公司采用用与品牌药相同的有效成分制作的仿...
The AARP has released a new report claiming that switching from brand name to generic drugs can save money for Americans in these tough economic times. 1 However, the Pharmaceutical Research and Manufacturers of America (PhRMA) has countered the claims, arguing that prescription drug spending has...
However, through the ANDA, the drug company must be able to demonstrate the generic version will work the same as an existing approved brand name drug in (as stated above) dosage form, safety, effectiveness, strength, route of administration, quality, and stability. These "sameness" character...
“Generic drugs are required to have the same active ingredient, strength, dosage form, and route of administration as the brand name product. Generic drug manufacturers must prove their product is the same as (bioequivalent) the brand name product.”– U.S. Food and Drug Administration[1] ...
The article focuses on the contention between the American Association of Retired Persons (AARP) and the Pharmaceutical Research and Manufacturers of America (PhRMA) about the pricing of generic and brand name drugs. There was a 9% increase in company prices of brand name prescription drugs in ...
Name Brand vs. Generic Drugs Drugs sold in the U.S. may be name-brand or generic. A name-brand drug can be patented for 20 years after its discovery or invention. Once the patent expires, other manufacturers can produce and market generic equivalents of that drug.11 ...
Generic Name / Ingredient Search by ingredient / generic name: Search Tradename Search by tradename: Search National Drug Code (NDC) Search by NDC number: Search Drug Price Spread Brand vs. Generic Drug Price Spread Brand vs. Generic Drug Price ...
Brand name and generic drug manufacturers filed briefs on the merits in the Supreme Court case challenging whether so-called "pay-for-delay" patent infringement lawsuit settlements are presumptively illegal under antitrust laws (Federal Trade Commission v. Watson Pharmaceuticals, U.S., No. 12-416,...
First, we analyzed the national drug data repositories of 31 countries1and the analysis helped us define a common set of properties which exist and which we want to use in our dataset. This set consisted of 24 properties, including the brand name of the drug, the generic name, the ATC co...